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ABSTRACT
Objectives: To identify pathogens associated with diarrhoea in HIV-infected persons 
and their HIV-uninfected family members. 
Design: Prospective cohort study. 
Setting: Rural community in eastern Uganda. 
Subjects: Eight hundred and seventy nine HIV-infected adults (74% females and median 
age 35 years (IQR, 29-41) and 2771 HIV-uninfected family members (51% females and 
median age 11 years (IQR 6-16) were included.
Main outcome measures: Using microscopy and culture, stools were tested for parasites, 
bacteria and bacterial-antimicrobial-susceptibility. Logistic regression models, 
adjusting for age, CD4 cells, season, household clustering and use of safe-water system 
were used for relationships between pathogens, diarrhoea and HIV. 
Results: Persons with HIV had similar pathogens in diarrhoeal (69%) and non-
diarrhoeal stools (57%). Most diarrhoea was not associated with identifiable aetiology; 
the population attributable risk of diarrhoea for known diarrhoea pathogens was 32%. 
Enteric bacteria (19%), enteropathogenic or enterotoxigenic E. coli (8%), Aeromonas 
species (7%), Strongyloides stercoralis (8%) and Cryptosporidium parvum (5%). HIV-
infected, stools had more Cryptosporidium parvum than HIV-uninfected (OR 2.64, 
95% CI 1.43-4.87). Most bacteria were resistant to commonly used antimicrobials 
irrespective of HIV status. 
Conclusions: Irrespective of HIV-status, aetiologies of majority of their diarrhoea in 
Uganda cannot be identified by microscopy and culture. Bacterial pathogens isolated 
have high resistance to common antimicrobials. Empiric treatment should be tailored 
to local bacterial-resistance patterns. 
INTRODUCTION
In sub-Saharan Africa, diarrhoea is a leading cause 
of morbidity in persons with HIV (l, 2). Previous 
studies of diarrhoea in persons with HIV in Africa 
have shown that in many cases the aetiologic agent 
cannot be identified (3, 4). The prevalence, type, and 
antimicrobial susceptibility of enteric pathogens 
isolated from stools of persons with HIV with 
diarrhoea exhibit variability across countries, which 
complicates effective empirical case management (5). 
To develop proper guidelines for effective empirical 
treatment and disease preventive practices among 
people with HIV, there is a need to develop a better 
understanding of the frequency of diarrhoea caused 
by specific pathogens and their susceptibility to 
antimicrobial agents. In addition, it is not known 
whether pathogens that are associated with 
diarrhoea among people with HIV differ from those 
affecting HIV-uninfected people living in the same 
environment. This information could be useful in the 
management of diarrhoea, particularly in determining 
whether different empiric therapy regimens should 
be developed depending on HIV status. 
 To obtain data on bacterial and parasitic 
pathogens associated with diarrhoea, and bacterial 
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antimicrobial susceptibility patterns, we collected 
and tested asymptomatic and symptomatic stool 
specimens from people with HIV, and symptomatic 
stool specimens from their HIV-uninfected household 
members during a longitudinal intervention trial in 
rural Uganda. This paper describes the findings of 
this evaluation. 
MATERIALS AND METHODS
Persons with HIV-1 infection who were clients of The 
AIDS Support Organisation (TASO) living in rural 
Tororo and Busia Districts, Uganda, without access 
to chlorinated municipality water were enrolled and 
followed-up. Enrollment consisted of two phases, 
identically implemented. The first from April to May 
2001 and the second, from January to March 2002 
(6). The study was designed to evaluate the efficacy 
of a safe water intervention and cotrimoxazole 
prophylaxis on morbidity and mortality among 
people with HIV and their household members. 
After five months of follow-up, all people with HIV 
began cotrimoxazole prophylaxis. Data on the safe 
water intervention (7) and co-trimoxazole (6) have 
been presented elsewhere. In this paper we include 
only data before participants with HIV started taking 
cotrimoxazole. 
 After written, informed consent was provided, 
study staff visited participants’ homes to conduct a 
census and obtain consent from household members. 
Consent forms and questionnaires were translated 
into six local languages and back-translated into 
English. A household was defined as persons who 
shared a hearth and slept in the same house or 
cluster of houses for at least five days of the week 
for the preceding three months. A finger stick 
sample of blood was collected from household 
members on filter paper for HIV testing. All persons 
were encouraged to receive HIV test results and 
counselling at home or at the project clinic at Tororo 
Hospital. 
 At enrollment, households of persons with HIV 
were randomly assigned to receive either a 20-litre 
polyethylene vessel with a narrow mouth and a 
spigot (Nampak Co., Johannesburg, South Africa), 
one 500 ml bottle of 0.5% sodium hypochlorite 
solution, a cloth for filtering water, and basic hygiene 
education, or education alone. Participants were 
interviewed about household demographic and 
socioeconomic characteristics, and water, hygiene, 
and sanitary practices. All HIV-positive participants 
received an assessment by a physician and provided 
blood samples for CD4 cell count enumeration and a 
stool sample for pathogen isolation. All participants 
with prevalent enteric helminths were offered 
treatment. 
 During weekly visits, study staff administered 
a questionnaire to all household members regarding 
diarrhoea episodes, days with diarrhoea, days of 
school or work lost and hospitalisation or death of 
a household member in the prior seven days. For 
cases of diarrhoea, defined as > 3 loose or watery 
stools in 24-hours, a stool specimen was collected 
and aliquoted. Field workers inserted two swabs 
into stool samples, transferred them to a tube of 
Cary Blair transport media, then placed one portion 
of stool in a tube of formal saline, and another into a 
sterile container for storage. All samples were placed 
on ice packs in a cooler, transported to the project 
laboratory, and refrigerated. All Cary Blair specimens 
were cultured within 48 hours of collection or frozen 
for future testing. Persons unable to provide a sample 
immediately were asked to insert two rectal swabs, 
which were immediately transferred into Cary Blair 
transport media, and were also given a specimen cup 
for a stool specimen that was retrieved later the same 
day. Diarrhoea was treated with oral rehydration 
solution and, if indicated, antimicrobial and anti-
motility agents. Only one stool sample was collected 
for each episode of diarrhoea. No patients received 
antiretroviral therapy, as it was not readily available 
in Uganda during the time of the study. 
Laboratory testing: Bacteria were isolated by culture 
after inoculating stool samples onto blood agar, 
Salmonella-Shigella agar, McConkey agar and sorbitol 
McConkey agar and later isolation of Salmonella, 
Shigella, Yersinia spp., Campylobacter spp. and Escherichia 
coli was done using selective and differential culture 
media. Enrichment of Salmonella was done by 
inoculation of stool samples in Selenite-F broth which 
was incubated for 18 hours at 37°C. This was later 
subcultured on S-S agar and incubated for 24 to 48 
hours. The different bacteria were identified using 
standard biochemical methods. 
 For isolation of Escherichia coli, stool samples 
were inoculated on McConkey agar and incubated at 
35-37°C overnight. A sweep of colonies with typical 
appearance of E. coli were taken from each plate, stored 
in 2 ml of Trypticase Soy Broth with 20% glycerol 
and later inoculated onto non-selective agar. After 
24 hours pure E. coli colonies were used to prepare 
DNA suspensions which were subsequently tested 
by polymerase chain reaction using positive and 
negative DNA probe controls for identification of 
enteropathogenic E. coli (EPEC) and enterotoxigenic 
Escherichia coli (ETEC) (8). Antimicrobial resistance 
for bacterial stool pathogens was measured using 
standard, disk-diffusion techniques (9). To identify 
ova, cysts, and parasites from formalinised whole 
stool samples, the Evergreen Concentrate Kits 
(formalin-ethyl acetate, Faecal Parasite Concentrator, 
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Evergreen Scientific, Los Angeles, CA, USA) were 
used, while the modified ZN stain was used to identify 
Cryptosporidium and microsporidia cysts. Stool 
specimens were also tested for Rotavirus using the 
Murex Rotavirus ELISA kit (Meo-Ox Diagnostics, Inc., 
Ottawa, Ontario, Canada). Frozen stool samples were 
thawed and stored for future testing for viruses. 
 For the index TASO clients, screening of their 
blood specimens for HIV infection was done using 
two enzyme-linked immunoassays (EIA) in parallel 
(Recombigen HIV-l/HIV-2, Trinity Biotech, Dublin, 
Ireland; and Murex HIV 120; Abbot Diagnostics, 
Chicago, Illinois). Specimens negative on both EIA 
screening tests were considered negative; specimens 
positive on both assays were considered positive. 
Specimens with discordant results were re-tested 
by Western Blot (LA V Blot, Biorad, Richmond, 
California). Dried blood spots from household 
members were screened for HIV using EIA 
(Vironostika HIV, BioMerieux, Durham, NC) and 
confirmation of reactive specimens by Western Blot. 
Polymerase chain reaction (PCR) was conducted on 
all HIV-reactive dried blood specimens (DBS) from 
children <24 months of age. CD4 cell counts were 
measured using standard procedures (FACScount; 
Becton- Dickinson, La Jolla, CA, Roche, New 
Jersey). 
Data analysis and management: Data were entered 
using Epi Info (CDC, Atlanta, GA, USA), and 
analysed using SAS version 9.1 (SAS Institute, 
Cary, NC, USA). The proportion of stool specimens 
yielding enteric pathogens (defined as bacteria or 
parasites that are associated with enteric illness) 
and diarrhoeal pathogens (defined as the sub-group 
of enteric pathogens that have well-documented 
associations with diarrhoea) in the different study 
groups were compared using the Chi-square test. 
Logistic regression models were used to compare 
the frequency of isolation of pathogens in stool 
samples obtained from persons with HIV with 
and without diarrhoea symptoms, adjusting for 
differences in CD4 cell counts, age, time of year, and 
presence of the safe water intervention, a latrine or 
soap in the household. Logistic regression models 
were used to compare the frequency of pathogen 
isolation from diarrhoeal stools in persons with 
HIV and HIV-negative family members, adjusting 
for the same factors. Estimation of the population 
attributable risk percent (PAR%) for enteric 
pathogens was calculated using previously defined 
methods (10). 
 The study protocol was approved by the Science 
and Ethics Committee of the Uganda Virus Research 
Institute, the Uganda National Council of Science and 
Technology, and the Institutional Review Board of the 
Centres for Disease Control and Prevention (CDC).
 
RESULTS
A total of 879 persons with HIV were enrolled, of 
whom 650 (74%) were female. The median age was 35 
years (interquartile range [IQR] 29-41 years) and 30% 
had CD4 cell counts <200 cells/mm3. At baseline 562 
(64%) participants with HIV provided non-diarrhoeal 
stool samples that were eligible for analysis. We 
excluded from baseline analysis 120 (14%) persons 
with HIV who did not provide stools samples, 185 
(21%) who had symptoms of diarrhoea within seven 
days of stool collection at baseline and 12 (1%) who 
had no CD4 cell counts results. During follow-up 269 
persons with HIV reported 503 episodes of diarrhoea, 
of which, 491 (98%) had a stool specimen available. 
Of these, 62% of participants had one episode of 
diarrhoea, 24% had two episodes, and 14% had three 
or more episodes of diarrhoea during follow-up. 
 Of 2771 HIV-uninfected family members, the 
median age was 11 years (IQR 6-16 years) and 1415 
(51 %) were female. Among the HIV -negative family 
members 229 persons had 310 episodes of diarrhoea, 
303 (98%) of which had an associated stool specimen 
available. Of these, 81% of participants had one 
episode of diarrhoea, 14% had two episodes, and 
5% had three or more episodes. The HIV-negative 
family members were younger (p-value <0.0001) 
and more likely to be male (P <0.0001) than persons 
with HIV. 
 At baseline 57% of stool specimens of persons with 
HIV without symptoms of diarrhoea had pathogens 
while 69% collected from persons with diarrhoea 
collected during follow-up had a pathogen, (Table 1). 
More than one pathogen was isolated from each of 
the 119 (21%) asymptomatic and 138 (28%) diarrhoeal 
stool samples of persons with HIV; and 86 (28%) stool 
samples of persons without HIV. Of the 562 stools 
collected from persons with HIV, 155 (28%) yielded 
one or more known diarrhoeal pathogens; of these 
17% yielded bacteria, 13% Strongyloides stercoralis, and 
2% yielded Cryptosporidium parvum. Stools collected 
during follow-up from persons with HIV with 
diarrhoea were more likely to yield one or more enteric 
pathogens, (69% vs. 57% adjusted odds ratio [OR] 1.63, 
confidence interval [CI] 1.25-2.12; p=0.0003), and as 
expected, more likely to yield diarrhoeal pathogens 
(51% vs. 28% adjusted odds ratio [OR] 2.69, confidence 
interval (CI) 2.05, 3.53; p<0.0001), than asymptomatic 
stools collected at baseline. Several specific diarrhoeal 
pathogens were more frequently isolated from 
diarrhoeal stools than asymptomatic stools collected 
at baseline, these included E. coli (enteropathogenic 
E. coli and enterotoxigenic E. coli), Aeromonas species, 
Strongyloides stercoralis and Cryptosporidium parvum, 
(Table 1). No Microsporidia was isolated from diarrhoeal 
and non-diarrhoeal stools. 
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The majority of diarrhoeal episodes were not 
attributable to a known pathogen; and known 
diarrhoeal pathogens accounted for only 32% of the 
population attributable risk percent for diarrhoea: 19% 
for enteric bacteria, 8% for E. coli, 7% for Aeromonas 
species, 8% for Strongyloides stercolaris, and 5% for 
Cryptosporidium parvum. Attributable risks for specific 
pathogens do not add to 32% due to the potential 
for isolation of multiple pathogens from one stool 
specimen. Diarrhoeal stools were less likely to yield 
hookworm compared to asymptomatic stools (OR) 
0.73, 95% CI, 0.55-0.97; p-value = 0.0304), (Table 1). 
During follow-up, pathogens were isolated in 
similar proportions from persons with HIV and 
HIV-negative family members, with the exception 
of Cryptosporidium parvum which was more frequent 
Table 1
Pathogens isolated from stools provided by symptomatic and asymptomatic persons with HIV, Tororo and Busia 
Districts, Uganda*
 
 Symptomatic  Asymptomatic Adjusted Odds  P-value Adjusted
 (n=436) (n=562) Ratio* (95%   population  
  No. (%)   No. (%)  Confidence    attributable
   Interval)   risk percent
Total number of stool samples 436 562    
Enteric pathogen  301 69  319  57  1.63 (1.25- 2.12)  0.0003  
Diarrhoeal pathogen  220 51  155  28  2.69 (2.05-3.53) <0.0001  32 
Bacteria  136 31  94   17  2.46 (1.82-3.32)  <0.0001  19 
  Campylobacter species  9    2 11    2  1.12 (0.48-2.59) 0.7981  
  Shigella species  26   6  21    4  1.60 (0.79-3.24)  0.1928  -
  Salmonella species  16   4  18    3  0.99 (0.53-1.87)  0.9770  -
  E. coli species ***  75  21  44   16  1.69 ( 1.08-2.63)  0.022  8 
  Aeromonas species  31   7 2    0.4  20.03 (4.69-85.5)  <0.0001  7 
Helminths  195 45  266  47  0.85 (0.66-1.10)  0.2278 
  Hookworms  140 32  225  40  0.73 (0.55-0.97)  0.0304  -
  Strongyloides stercoralis  84  19  70   13  1.47 (1.04-2.07)  0.0290  8
  Schistosoma mansoni  15   3  12    2  1.81 (0.88-3.70)  0.1068  -
  Ascaris lumbricoides  2   0.5  1    0.2  2.59 (0.23-28.6)  0.40571  -
Protozoa  65  15  67   12  1.32 (0.90-1.93)  0.1545  -
  Cryptosporidium parvum  30   7  9     2  3.72 (1.56-8.88)  0.0031  5
  Giardia lamblia  7    2  3    0.5  2.89 (0.93-8.97)  0.0658  -
*More than one pathogen was isolated from the same stool specimen 
**Odds Ratios and population attributable risk were adjusted for age, CD4 cell counts, presence 
of safe water intervention, household clustering and season, use of a latrine and washing hands 
with soap after visiting the latrine. 
*** For the evaluation of E. coli, 353 symptomatic and 280 asymptomatic stool samples were used 
in the analysis. 
1Fishers exact test. 
among persons with HIV (OR 2.64,95% CI 1.43-4.87), 
and hookworms, which were more frequent among 
family members (OR 0.61 CI, 0.42-0.89, p-value = 0.01 
12), (Table 2). Only one stool sample, from a person 
with HIV during follow-up, yielded rotavirus. 
At CD4 cell counts <200 cells/µL, diarrhoeal stool 
samples of persons with HIV were more likely, than 
at CD4 counts >200 cells/µL, to have detectable 
diarrhoeal pathogens (58% vs. 49%, OR 1.64,95% 
CI, 1.21-2.22): Cryptosporidium parvum (12% vs. 4%, 
OR 3.52, CI, 1.53-9.10), and Strongyloides stercoralis 
(24% vs. 15%, OR 2.01, CI, 1.36-2.99). We assessed for 
interaction between the safe water intervention and 
pathogens associated with diarrhoea and since we 
found none, we therefore combined the two study 
arms when presenting results. 
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Table 2
Enteric pathogens isolated from diarrhoeal stools provided by persons with HIV and HIV-negative family members, 
Tororo and Busia Districts, Uganda†
 Persons with  HIV-negative Adjusted odds P-value
 HIV  family members  Ratio* (95%    
 (n=491)  (n=303)  Confidence
 No.  (%) No.  (%) Interval)
Total Number of stools samples 491  303     
Enteric pathogen  336  68  196  65  1.08 (0.76-l.56) 0.6455 
Diarrhoeal pathogen  246  50  140  46  1.44 (1.02-2.01)  0.0357 
Bacteria  159  32  107  35  1.27(0.87-1.86)  0.2154 
  Aeromonas species  36    7  24    8  1.07 (0.54-2.10)  0.8506 
  Campylobacter species  14    3  15    5 1.25 (0.48-3.31)  0.6472 
  Salmonella species  18    4 17    6 0.60 (0.29-1.24)  0.1688 
  Shigella species  29    6  9     3 1.92 (0.94-3.94)  0.0743 
  E. coli species1  88   22  64   26  1.22 (0.77-1.92)  0.3961 
Helminths  213  43  113  37  0.78 (0.55-1.13)  0.1896 
  Strongyloides stercoralis  90   18  36   12  1.23 (0.72-2.09)  0.4486 
  Hookworms2  154  31  97   32  0.61 (0.42-0.89)  0.0112 
Protozoa  67   14  39   13  0.98 (0.60-1.59)  0.9369 
  Cryptosporidium parvum  30    6  10    3  2.64 (1.43-4.87)  0.0018 
  Isospora belli  2    0.4  0     0  
†  More than one pathogen could be isolated from the same stool specimen. 
* Odds Ratios were adjusted for age, presence of safe water intervention, household clustering and 
season, use of a latrine and washing hands with soap after visiting the latrine. 
1  E. coli was assessed in 406 stool samples from HIV-infected persons with diarrhoea and 249 
samples from HIV-negative family members with diarrhoea. 
2  Adults had 3.7 times more hookworms than children aged <5 years; (OR 3.66,95% CI, 2.18-6.15, 
P-value < 0.0001). 
Antimicrobial resistance patterns of enteric bacterial 
isolates: The bacterial isolates from diarrhoeal stool 
samples obtained during follow-up from persons 
with and without HIV were frequently resistant to 
commonly used antimicrobial agents (Table 3). No 
significant differences were seen in bacterial resistance 
to antimicrobial agents by HIV status. Resistance of 
Aeromonas, Shigella, Campylobacter and E.coli species 
to cotrimoxazole, chloramphenicol, and ampicillin 
ranged from 44 to 100%, while Salmonella species 
had lower levels of resistance to all antimicrobial 
agents. All bacteria were sensitive to nalidixic acid, 
ciprofloxacin and furazolidone with the exception of 
Aeromonas species (Table 3). 
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Table 3
Antimicrobial resistance of enteric bacteria isolated from stool specimens from persons with HIV and their HIV 
uninfected household members, Tororo and Busia Districts, Uganda
Bacteria HIV  No.  Ampicillin  Chloramphenicol  Cotrimoxazole  Nalidixic Ciprofloxacin Furazolidine
 status Isolates (% resistant) (% resistant) (% resistant) acid  (% resistant)  (% resistant) 
           (% resistant)     
All bacteria  Positive  188  67  35  73  5  5  0 
 Negative  134  64  31  66  7  5  0 
Aeromonas  Positive 36 97  50 63 33 26 0 
Species Negative 24 100 61 83 58 29 0 
Shigella  Positive  29 72 76 93 0 0 NT 
Species* Negative  9 44 44 89 0 0 NT 
Salmonella  Positive  18 33 28 33 0 0 NT 
Species* Negative  16 13 12 13 0 0 NT 
Campylobacter  Positive   14 NT NT  92 NT 0 NT
species*  Negative  15 NT  NT  100 NT 0 NT
ETEC  Positive   52 56 14 85 0 0 0
 Negative  47 62 23 60 0 0 0
EPEC  Positive   36 61 28 69 0 0 0 
 Negative  22 76 29 73 0 0 0
* Campylobacter species were not tested for sensitivity to ampicillin, chloramphenicol and 
furazolidone, and isolates of Shigella species and Salmonella species were not tested for sensitivity 
to furazolidone. 
NT = Not Tested.
DISCUSSION
In this longitudinal cohort of people with HIV and 
their HIV-uninfected family members, although 
diarrhoeal pathogens were identified from 69% of 
diarrhoeal and 57% of non-diarrhoeal stools, only 
32% of diarrhoea episodes could be ascribed to an 
identifiable enteric pathogens. The most common 
pathogens associated with diarrhoea among persons 
with HIV were bacteria such as E. coli, Aeromonas 
species, Shigella, and Salmonella, and opportunistic 
parasites, such as Strongyloides stercoralis and 
Cryptosporidium parvum. The bacterial pathogens 
associated with diarrhoea among HIV-negative family 
members were also similar. The aetiology of the 
majority of diarrhoea occurring in persons with and 
without HIV in Uganda cannot be easily identified 
through conventional pathogen isolation measures (3, 
11, 12) . It may be that non-rotavirus viral pathogens, 
or as yet unidentified bacteria or parasites are causing 
a substantial proportion of diarrhoea. 
 In most studies of diarrhoea among persons with 
HIV, when a pathogen was isolated opportunistic 
infections were the major causes of diarrhoea (3, 
11, 13). However, in this study, bacteria were most 
frequently associated with diarrhoea, regardless of 
CD4 cell count. This may be due to several factors. 
First, we collected and processed stool specimens in 
the field which may have increased sensitivity for 
detecting bacterial pathogens; and secondly, our study 
was community-based, whereas most others have 
been clinic or hospital-associated. These differences 
may have enabled us to better detect pathogens 
associated with acute diarrhoea in comparison with 
other studies that may have collected stool specimens 
later in the course of illness, or after antimicrobial 
treatment had been initiated, processed samples after 
several hours at ambient temperature, or included 
more severe cases of diarrhoea that were associated 
with a clinic visit or hospitalisation. 
 There are indications that bacteria are more 
likely to be associated with acute diarrhoea, and 
opportunistic pathogens with chronic diarrhoea. Similar 
to previous studies, we found an association between 
immune suppression and Strongyloides stercoralis and 
Cryptosporidium parvum infection (14, 15). 
 Persons with HIV in this study had similar 
pathogens isolated from stools as HIV-negative family 
members, with the exception of Cryptosporidium 
parvum, Strongyloides stercoralis, and hookworms. 
This is similar to other studies, where pathogens 
from diarrhoeal stools of persons with HIV did not 
differ from those of persons without HIV (13, 16, 17), 
primarily with regard to opportunistic pathogens (11, 
18). In previous analyses from this study published 
elsewhere, we found that episodes of diarrhoea 
were six times as common among HIV-infected as 
HIV-uninfected people, and lower CD4 cell count 
was associated with a threee times increased risk 
for diarrhoea (6, 7). Together, these data suggest that 
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people with HIV are more likely to become ill with 
diarrhoea than HIV-uninfected people, but primarily 
with the same pathogens until their immune response 
is severely reduced. At that time, while they continue 
to develop diarrhoea from common pathogens, illness 
risk from opportunistic pathogens increases. 
 The collection of asymptomatic stool samples 
from persons with HIV at baseline was useful for 
the calculation of the population attributable risk 
percent. Although pathogens were isolated from 70% 
of diarrhoeal stools, calculation of the population 
attributable risk percent attributed only 32% of 
episodes of diarrhoea to a pathogen. Other studies have 
however reported higher proportion of identifiable 
agents from diarrhoea episodes among persons with 
HIV. Furthermore, pathogens are also present in the 
stool of people with HIV have no diarrhoea. 
 HIV-negative family members were more 
commonly infected with hookworms than HIV -
infected people. This is likely due to a study artifact; 
we collected asymptomatic stools from people 
with HIV at baseline and treated all people with 
hookworms. Thus, during follow-up, the presence 
of hookworms in a stool specimen from an HIV-
infected participant likely represented an incident 
infection. This hypothesis is supported by the finding 
that hookworm infections were significantly more 
prevalent in baseline asymptomatic stools than in 
follow-up diarrhoeal stools in the same population 
of HIV positive persons. Since baseline stools were 
not collected from HIV-negative family members, the 
finding of hookworms among them during follow-up 
represented both prevalent and incident infection. 
This is also probable age confounding, since persons 
with HIV were adults and the HIV-negative family 
members mainly children, who often have higher 
prevalence of hookworms. Although an association 
between the presence of hookworms and higher 
CD4 cell counts among HIV-infected adults has 
been reported in Uganda (19, 20), because of these 
study design limitations we could not assess this 
question. 
 Antimicrobial resistance to the less expensive and 
most commonly used agents, such as cotrimoxazole, 
ampicillin, and chloramphenicol is very high in 
this community. However, resistance is rare to less 
frequently used and more expensive drugs like 
furazolidone, nalidixic acid and ciprofloxacin. For 
episodes of severe diarrhoea that require empiric 
treatment in this region, it would be best to avoid 
the drugs that have limited efficacy, especially 
cotrimoxazole prophylaxis which is currently 
recommended for all people with HIV in Uganda by 
the Ministry of Health. The finding that resistance 
patterns were similar for persons with and without 
HIV is encouraging, and would allow for the 
development of standard treatment guidelines that 
do not differentiate by HIV status. 
 This study was not able to determine the 
aetiological fraction for the HIV-negative family 
members, for comparison with that of persons with 
HIV, since at baseline asymptomatic stool specimens 
were not collected from this population. Furthermore, 
this study may have underestimated E. coli in 
this study since there was not enough of the stool 
specimens for PCR for 20% of stool specimens. 
 In most cases of diarrhoea among persons with 
HIV in this community-based study in Uganda, 
microscopy, bacterial culture and Rotavirus testing 
could not identify the causative agents. For those 
episodes for which pathogens were isolated, there was 
no difference in the type of bacteria isolated between 
HIV-infected and uninfected persons; however, 
HIV-infected persons were more likely to be infected 
with Strongyloides stercoralis and Cryptosporidium 
parvum. These findings suggest that additional 
empiric treatment for Strongyloides stercoralis might be 
considered in the case of persons with HIV infection 
who do not respond to standard antimicrobial agents. 
For persons with HIV more studies are needed to 
determine the microbiologically detectable pathogens 
responsible for majority of diarrhoeal diseases among 
persons with HIV, which may need more improved 
diagnostic tests. 
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